MicroRNAs as emerging biomarkers for chronic wound monitoring: Analytical methods for the point-of-care detection

Diego Alvarez-Rafael1, Alfredo de la Escosura-Muñiz1

  • 1NanoBioAnalysis Group-Department of Physical and Analytical Chemistry, University of Oviedo, Julián Clavería 8, Oviedo 33006, Spain; Biotechnology Institute of Asturias, University of Oviedo, Santiago Gascon Building, Oviedo 33006, Spain.

Insights

MicroRNAs show promise as diagnostic biomarkers for chronic wound monitoring. This review assesses point-of-care technologies for detecting these biomarkers in wound management.

Area of Science:

  • Biomolecular diagnostics
  • Wound healing research
  • Point-of-care testing technologies

Background:

  • Chronic wounds pose significant clinical challenges, characterized by delayed healing and high infection rates.
  • MicroRNAs (miRNAs) are key regulators of wound healing phases: inflammation, proliferation, and remodeling.
  • Emerging molecular diagnostics highlight miRNAs as potential real-time wound status biomarkers.

Purpose of the Study:

  • To review the diagnostic potential of microRNAs in chronic wound management.
  • To focus on analytical strategies for point-of-care (POC) detection of wound-related miRNAs.
  • To critically evaluate current technologies for their sensitivity, specificity, and usability in decentralized settings.

Main Methods:

  • Literature review of microRNA biomarkers in chronic wound healing.
  • Analysis of analytical techniques for miRNA detection, including paper-based assays and electrochemical methods.
  • Assessment of technology integration and usability for point-of-care applications.

Main Results:

  • MicroRNAs are validated regulators across all wound healing stages.
  • Several analytical strategies show potential for sensitive and specific miRNA detection.
  • Point-of-care technologies like lateral flow assays and electrochemical sensors are promising for decentralized wound monitoring.

Conclusions:

  • MicroRNAs hold significant potential as diagnostic biomarkers for effective chronic wound management.
  • Point-of-care detection methods are crucial for real-time monitoring and timely clinical intervention.
  • Further development and validation of POC technologies are needed to enhance sensitivity, specificity, and usability in diverse healthcare settings.